
Kevin E. Weddington
Examiner (ID: 6966)
| Most Active Art Unit | 1614 |
| Art Unit(s) | 1614, 1205, 1629, 2899 |
| Total Applications | 3386 |
| Issued Applications | 2180 |
| Pending Applications | 434 |
| Abandoned Applications | 815 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 5041149
[patent_doc_number] => 20070093431
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-04-26
[patent_title] => 'COMBINATION OF ORGANIC COMPOUNDS'
[patent_app_type] => utility
[patent_app_number] => 11/614401
[patent_app_country] => US
[patent_app_date] => 2006-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4976
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0093/20070093431.pdf
[firstpage_image] =>[orig_patent_app_number] => 11614401
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/614401 | COMBINATION OF ORGANIC COMPOUNDS | Dec 20, 2006 | Abandoned |
Array
(
[id] => 4432808
[patent_doc_number] => 07897572
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2011-03-01
[patent_title] => 'Theraputic methods for type I diabetes'
[patent_app_type] => utility
[patent_app_number] => 11/643480
[patent_app_country] => US
[patent_app_date] => 2006-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 8
[patent_no_of_words] => 39427
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 95
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/897/07897572.pdf
[firstpage_image] =>[orig_patent_app_number] => 11643480
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/643480 | Theraputic methods for type I diabetes | Dec 20, 2006 | Issued |
Array
(
[id] => 4866350
[patent_doc_number] => 20080145409
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-06-19
[patent_title] => 'COMPOSITION FOR THE TREATMENT AND PREVENTION OF PEPTIC ULCER'
[patent_app_type] => utility
[patent_app_number] => 11/612549
[patent_app_country] => US
[patent_app_date] => 2006-12-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5443
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0145/20080145409.pdf
[firstpage_image] =>[orig_patent_app_number] => 11612549
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/612549 | COMPOSITION FOR THE TREATMENT AND PREVENTION OF PEPTIC ULCER | Dec 18, 2006 | Abandoned |
Array
(
[id] => 177954
[patent_doc_number] => 07655662
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-02-02
[patent_title] => '(Indazol-5-yl)-pyrazines and (1,3-dihydro-indol-2-one)-pyrazines for treating glaucoma and controlling intraocular pressure'
[patent_app_type] => utility
[patent_app_number] => 11/612894
[patent_app_country] => US
[patent_app_date] => 2006-12-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5244
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/655/07655662.pdf
[firstpage_image] =>[orig_patent_app_number] => 11612894
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/612894 | (Indazol-5-yl)-pyrazines and (1,3-dihydro-indol-2-one)-pyrazines for treating glaucoma and controlling intraocular pressure | Dec 18, 2006 | Issued |
Array
(
[id] => 8944119
[patent_doc_number] => 08497298
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-07-30
[patent_title] => 'Use of benzo-fused heterocycle sulfamide derivatives for lowering lipids and lowering blood glucose levels'
[patent_app_type] => utility
[patent_app_number] => 11/611961
[patent_app_country] => US
[patent_app_date] => 2006-12-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17873
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11611961
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/611961 | Use of benzo-fused heterocycle sulfamide derivatives for lowering lipids and lowering blood glucose levels | Dec 17, 2006 | Issued |
Array
(
[id] => 5120654
[patent_doc_number] => 20070142369
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-06-21
[patent_title] => 'Combination of an H3 antagonist/inverse agonist and an appetite suppressant'
[patent_app_type] => utility
[patent_app_number] => 11/640729
[patent_app_country] => US
[patent_app_date] => 2006-12-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16952
[patent_no_of_claims] => 55
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0142/20070142369.pdf
[firstpage_image] =>[orig_patent_app_number] => 11640729
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/640729 | Combination of an H3 antagonist/inverse agonist and an appetite suppressant | Dec 17, 2006 | Abandoned |
Array
(
[id] => 5041171
[patent_doc_number] => 20070093453
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-04-26
[patent_title] => 'Sulfonamide-substituted chalcone derivatives and their use to treat diseases'
[patent_app_type] => utility
[patent_app_number] => 11/640509
[patent_app_country] => US
[patent_app_date] => 2006-12-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 42091
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0093/20070093453.pdf
[firstpage_image] =>[orig_patent_app_number] => 11640509
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/640509 | Sulfonamide-substituted chalcone derivatives and their use to treat diseases | Dec 14, 2006 | Abandoned |
Array
(
[id] => 5429152
[patent_doc_number] => 20090088462
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-04-02
[patent_title] => 'Pharmaceutical Composition for Enhancing Adiponectin Production'
[patent_app_type] => utility
[patent_app_number] => 12/086363
[patent_app_country] => US
[patent_app_date] => 2006-12-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 3943
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0088/20090088462.pdf
[firstpage_image] =>[orig_patent_app_number] => 12086363
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/086363 | Pharmaceutical Composition for Enhancing Adiponectin Production | Dec 13, 2006 | Abandoned |
Array
(
[id] => 5254063
[patent_doc_number] => 20070135519
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-06-14
[patent_title] => 'Chemoprotective methods and compositions'
[patent_app_type] => utility
[patent_app_number] => 11/638193
[patent_app_country] => US
[patent_app_date] => 2006-12-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 19244
[patent_no_of_claims] => 327
[patent_no_of_ind_claims] => 17
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0135/20070135519.pdf
[firstpage_image] =>[orig_patent_app_number] => 11638193
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/638193 | Chemoprotective methods and compositions | Dec 12, 2006 | Issued |
Array
(
[id] => 173535
[patent_doc_number] => 07658914
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-02-09
[patent_title] => 'Colon cleansing compositions'
[patent_app_type] => utility
[patent_app_number] => 11/636105
[patent_app_country] => US
[patent_app_date] => 2006-12-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16464
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 51
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/658/07658914.pdf
[firstpage_image] =>[orig_patent_app_number] => 11636105
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/636105 | Colon cleansing compositions | Dec 7, 2006 | Issued |
Array
(
[id] => 5254065
[patent_doc_number] => 20070135521
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-06-14
[patent_title] => 'Agent for Preventing Metabolic Syndrome'
[patent_app_type] => utility
[patent_app_number] => 11/567038
[patent_app_country] => US
[patent_app_date] => 2006-12-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 6075
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0135/20070135521.pdf
[firstpage_image] =>[orig_patent_app_number] => 11567038
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/567038 | Agent for Preventing Metabolic Syndrome | Dec 4, 2006 | Abandoned |
Array
(
[id] => 4460990
[patent_doc_number] => 07879859
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-02-01
[patent_title] => 'Diagnosis and treatment of type 2 diabetes and other disorders'
[patent_app_type] => utility
[patent_app_number] => 11/664381
[patent_app_country] => US
[patent_app_date] => 2006-11-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 2
[patent_no_of_words] => 7737
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/879/07879859.pdf
[firstpage_image] =>[orig_patent_app_number] => 11664381
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/664381 | Diagnosis and treatment of type 2 diabetes and other disorders | Nov 16, 2006 | Issued |
Array
(
[id] => 5284593
[patent_doc_number] => 20090098268
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-04-16
[patent_title] => 'LIQUID SEASONING'
[patent_app_type] => utility
[patent_app_number] => 12/093676
[patent_app_country] => US
[patent_app_date] => 2006-11-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15003
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0098/20090098268.pdf
[firstpage_image] =>[orig_patent_app_number] => 12093676
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/093676 | Liquid seasoning | Nov 13, 2006 | Issued |
Array
(
[id] => 4989409
[patent_doc_number] => 20070155750
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-07-05
[patent_title] => 'INTEGRIN-BINDING SMALL MOLECULES'
[patent_app_type] => utility
[patent_app_number] => 11/559857
[patent_app_country] => US
[patent_app_date] => 2006-11-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 24568
[patent_no_of_claims] => 60
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0155/20070155750.pdf
[firstpage_image] =>[orig_patent_app_number] => 11559857
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/559857 | Integrin-binding small molecules | Nov 13, 2006 | Issued |
Array
(
[id] => 4983515
[patent_doc_number] => 20070088074
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-04-19
[patent_title] => 'ARTICLE OF MANUFACTURE COMPRISING AROMATIC AMINO ACIDS ISOMERS, ANALOGS, OR DERIVATIVES THEREOF TO TREAT NEUROLOGICAL DISORDERS INVOLVING DYSFUNCTION OF GLUTAMATERGIC SYNAPTIC TRANSMISSION'
[patent_app_type] => utility
[patent_app_number] => 11/559186
[patent_app_country] => US
[patent_app_date] => 2006-11-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 6561
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0088/20070088074.pdf
[firstpage_image] =>[orig_patent_app_number] => 11559186
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/559186 | ARTICLE OF MANUFACTURE COMPRISING AROMATIC AMINO ACIDS ISOMERS, ANALOGS, OR DERIVATIVES THEREOF TO TREAT NEUROLOGICAL DISORDERS INVOLVING DYSFUNCTION OF GLUTAMATERGIC SYNAPTIC TRANSMISSION | Nov 12, 2006 | Abandoned |
Array
(
[id] => 5113636
[patent_doc_number] => 20070197552
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-08-23
[patent_title] => 'Method and composition for treatment of diabetes, hypertension, chronic heart failure and fluid retentive states'
[patent_app_type] => utility
[patent_app_number] => 11/598396
[patent_app_country] => US
[patent_app_date] => 2006-11-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 23417
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0197/20070197552.pdf
[firstpage_image] =>[orig_patent_app_number] => 11598396
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/598396 | Method and composition for treatment of diabetes, hypertension, chronic heart failure and fluid retentive states | Nov 12, 2006 | Abandoned |
Array
(
[id] => 5096154
[patent_doc_number] => 20070117763
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-05-24
[patent_title] => 'Compositions and methods for treatment and prevention of metabolic syndrome and its associated conditions with combinations of flavonoids, liminoids and tocotrienols'
[patent_app_type] => utility
[patent_app_number] => 11/595558
[patent_app_country] => US
[patent_app_date] => 2006-11-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 8270
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0117/20070117763.pdf
[firstpage_image] =>[orig_patent_app_number] => 11595558
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/595558 | Compositions and methods for treatment and prevention of metabolic syndrome and its associated conditions with combinations of flavonoids, liminoids and tocotrienols | Nov 9, 2006 | Abandoned |
Array
(
[id] => 8177654
[patent_doc_number] => 08178675
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-05-15
[patent_title] => 'Compounds for the treatment of metabolic disorders'
[patent_app_type] => utility
[patent_app_number] => 12/092932
[patent_app_country] => US
[patent_app_date] => 2006-11-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 13302
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/178/08178675.pdf
[firstpage_image] =>[orig_patent_app_number] => 12092932
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/092932 | Compounds for the treatment of metabolic disorders | Nov 8, 2006 | Issued |
Array
(
[id] => 5080361
[patent_doc_number] => 20070123585
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-05-31
[patent_title] => 'Nitroglycerin therapy for those unable to metabolize nitroglycerin'
[patent_app_type] => utility
[patent_app_number] => 11/594214
[patent_app_country] => US
[patent_app_date] => 2006-11-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2919
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0123/20070123585.pdf
[firstpage_image] =>[orig_patent_app_number] => 11594214
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/594214 | Nitroglycerin therapy for those unable to metabolize nitroglycerin | Nov 7, 2006 | Issued |
Array
(
[id] => 7688863
[patent_doc_number] => 20070105835
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-05-10
[patent_title] => 'Compositions and methods for modulating poly(ADP-ribose) polymerase activity'
[patent_app_type] => utility
[patent_app_number] => 11/593902
[patent_app_country] => US
[patent_app_date] => 2006-11-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 15437
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0105/20070105835.pdf
[firstpage_image] =>[orig_patent_app_number] => 11593902
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/593902 | Compositions and methods for modulating poly(ADP-ribose) polymerase activity | Nov 6, 2006 | Abandoned |